Business
Serena Williams invests in women’s basketball league Unrivaled, now valued at $340 million
Serena Williams introduces Maria Sharapova during the 2025 Induction Celebration weekend at the International Tennis Hall of Fame in Newport, Rhode Island, on Aug. 23, 2025.
Joe Buglewicz | Getty Images Sport | Getty Images
Women’s 3-on-3 basketball league Unrivaled is now valued at $340 million after a new funding round that included tennis legend Serena Williams, the league announced Monday.
Williams’ Serena Ventures was part of a Series B funding round that was led by Bessemer Venture Partners and also included Warner Bros. Discovery and Alex Morgan’s Trybe Ventures. Unrivaled did not disclose the size of the individual contributions.
Unrivaled’s latest cash infusion means a dramatic rise in its valuation from just one year ago when the league was valued at $95 million, according to a person familiar with the league who spoke on the condition of anonymity about internal matters.
The investment comes as women’s sports have soared in both popularity and valuations in recent years.
“To add arguably the most iconic female athlete to play sports, I think it exemplifies who Unrivaled is not just with our players on the court, but the number of investors on our cap table who had been icons in their own lanes,” said Alex Bazzell, co-founder and president of Unrivaled.
Angel Reese, #5 of Rose, goes up for a shot against Napheesa Collier, #24 of the Lunar Owls, during the second half at Wayfair Arena in Medley, Florida, on Feb. 21, 2025.
Rich Storry | Getty Images Sport | Getty Images
Other Unrivaled investors include high-profile names such as tennis legend Billie Jean King, NBA superstar Stephen Curry, tennis champion Coco Gauff and Olympic swimmer Michael Phelps.
Bessemer has previously invested in ticketing resale site StubHub, as well as streaming services BallerTV and Twitch. The venture firm sees Unrivaled as a blueprint for the next generation of sports leagues, according to Caty Rea, a vice president at Bessemer.
“We always look for category-defining businesses with generational tail winds and really audacious founders who kind of have that product hard to fit,” Rea said. “We felt like we found that with Unrivaled.”
Unrivaled was founded in 2023 and offers women’s professional basketball players a league that runs in the offseason of the WNBA. Previously, many players went abroad in the offseason for extra compensation.
The league says it offers women the highest average salary in professional women’s sports history and provides equity to players.
For comparison, the WNBA does not offer its players equity, and players are currently negotiating their collective bargaining agreement, which expires Oct. 31. One of the key issues being debated is an increase in player compensation. WNBA Commissioner Cathy Engelbert told CNBC in July that the average WNBA team valuation has increased to about $260 million.
Bazzell said the new funding will be used to add more resources to the league’s facilities, for developmental efforts and to create additional awareness of the league as it heads into its second season.
“We’ve built a sustainable and sticky audience, both on television and certainly on social. So now we have to grow that footprint,” he said.
Business
Interest rate cuts not on the horizon, Bank of England governor says
Reopening the Strait of Hormuz is “the best thing to do” to prevent interest rates rising, Bank of England governor Andrew Bailey has said.
In an interview on Thursday evening after the Bank’s Monetary Policy Committee (MPC) voted unanimously to leave the rate unchanged at 3.75%, Mr Bailey said any further cuts are “not on the horizon” as he hinted at possible hikes.
It is the first time that all members have voted the same way since September 2021.
Iran effectively closed the vital oil and gas shipping route after the US and Israel attacked the country, which has pushed up global prices.
Mr Bailey said the war in the Middle East is hitting petrol pumps now, will likely increase household energy costs in summer, and put pressure on food prices.
He told LBC’s Andrew Marr: “The duration of this problem is crucial.
“I would also say very clearly that the best way to solve this situation is not through monetary policy. It is through sorting out at the source of what’s going on.
“Frankly, reopening the Strait of Hormuz is the best thing to do. Get the energy market back on its normal footing, as it were.”
Asked if he has a message for US President Donald Trump, Israeli Prime Minister Benjamin Netanyahu, and “whoever’s in charge in Tehran”, Mr Bailey said: “The best thing we can do actually for the world economy… is to sort out the problem in terms of reopening the energy supply lines, because that is in the best interest of people in the world.”
UK military planners have joined the US Central Command to help formulate proposals for opening the Strait.
The MPC now expects Consumer Prices Index inflation to be around 3% in the second quarter of 2026, up from the 2.1% that had been forecast in February, with a potential rise in inflation up to 3.5% in the third quarter.
Mr Bailey was asked if he foresees, in the final two years of his term, the ambition to reduce inflation to at or below 2% being fulfilled.
He told the programme: “If you’d asked me this question three weeks ago, I was very optimistic on this.”
The governor added: “We are fully committed to the inflation target, and our job, frankly, is to deal with the shocks as they come along.
“I have to do that. I don’t wish them. I wish they were not happening, but they are and we will have to deal with them.”
He said the impact of the war will likely feed through into a higher Ofgem energy price cap from July.
It was put to Mr Bailey that the Middle East crisis comes at a time when the UK economy has already “not been growing strongly”.
He responded: “It is a very difficult time to have this happen, but frankly, any time would be pretty difficult to have this happen.
“This is a major shock to energy prices, and we have to deal with it.”
He said the “sustainable rate of growth” in the UK needs to be raised which could come from investment from pensions and artificial intelligence.
“I’m not starry-eyed about it, but it is probably the most likely area that we’re going to raise the growth rate of the economy and that’s important”, he said of AI.
The MPC signalled that if the conflict persists and has a bigger impact on UK prices, it would need to take a “more restrictive policy stance”, which indicates higher interest rates to control inflation.
The governor added: “The longer it goes on… I’m afraid to say, but it is rather an obvious point, the effect will be larger.”
He said that is why it is “imperative” that “everything is done that can be done to alleviate this effect”, adding: “That is the critical thing.”
Business
Video: The Effects of High Oil Prices
new video loaded: The Effects of High Oil Prices
By Ben Casselman, Sutton Raphael, James Surdam, Joey Sendaydiego, Estelle Caswell and June Kim
March 19, 2026
Business
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026.
Tom Little | Reuters
The Food and Drug Administration on Thursday approved a higher-dose version of Novo Nordisk‘s blockbuster weight loss injection Wegovy, as the company pushes to win back market share from chief rival Eli Lilly.
Novo expects to launch the higher, 7.2-milligram dose of Wegovy in April. The Danish drugmaker is positioning that version to better compete with Lilly’s obesity drug Zepbound, which has proven to be more effective at promoting weight loss than the standard, 2.4-milligram dose of Wegovy.
That higher efficacy has helped Zepbound become the preferred obesity medication among prescribers and patients, even though it entered the U.S. market later than Wegovy, and has solidified Lilly’s position as the dominant player in the space.
The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial. The standard dose of Wegovy has shown around 15% weight loss on average in clinical trials.
“I think it really makes it more competitive, and it really reduces the delta there,” Dr. Jason Brett, principal U.S. medical head at Novo Nordisk, said in an interview Thursday ahead of the approval.
“But even more importantly, I think it just gives patients another option if they’re not reaching their targets, and achieving some of these higher weight losses for certain patients,” he added.
In a separate phase three trial on patients with obesity and Type 2 diabetes, high-dose Wegovy demonstrated an average weight loss of 14.1%. People with diabetes typically have a harder time losing weight than people without the condition.
It marks the first approval of a GLP-1 treatment under the FDA’s new national priority voucher plan that aims to cut drug review times to one to two months for companies the agency says are supporting U.S. national health priorities. The FDA launched the pilot plan in June.
-
Business1 week agoStock market crash today (March 12, 2026): Nifty50 opens below 23,600; BSE Sensex down over 900 points on continuing US-Iran war – The Times of India
-
Fashion1 week agoUK’s Topshop unveils Tolu Coker capsule collection
-
Business1 week agoUS ignites Iran war, but Gulf Arab states pay the price | The Express Tribune
-
Fashion1 week agoIndia’s textile recycling market may reach $3.5 bn by 2030: Report
-
Tech1 week agoMeta Developed 4 New Chips to Power Its AI and Recommendation Systems
-
Business1 week ago8th Pay Commission: How Much Will Central Govt Employees’ Salaries Rise? What We Know So Far
-
Sports1 week agoBangladesh crush Pakistan in ODI series opener | The Express Tribune
-
Entertainment1 week agoGas, food, household prices explained
